Nestle to Build Infant Formula Plant in Brazil in $393 Million Investment

• The nutrition and health investment represents approximately 30% of Nestle's total $1.37 billion commitment to Brazil between 2025 and 2028
• The new Ituiutaba factory will initially produce Nestogeno, Nestonutri, Ninho 1+, and Ninho 3+ infant formulas for the Brazilian market currently served partly through imports
• Nestle identifies Nutrition and Health as one of four strategic global growth priorities, representing some of the company's highest-value product categories

Nestle to Invest $393 Million in Brazilian Infant Formula Plant

Nestle announced a 2 billion reais ($393 million) investment in its nutrition and health division in Brazil through 2028, with 600 million reais allocated to construct a new infant formula factory in Minas Gerais state.

Key Investment Details:

• The nutrition and health allocation represents approximately 30% of Nestle's total 7 billion reais ($1.37 billion) investment planned for Brazil between 2025-2028
• New factory location: Ituiutaba, Minas Gerais
• Construction timeline: begins 2027, operations commence 2028
• Initial production: Nestogeno, Nestonutri, Ninho 1+, and Ninho 3+ infant formula brands

Strategic Rationale:

The facility aims to increase domestic supply in the Brazilian market, which currently relies partially on imports, while creating potential future export opportunities. Nestle Brasil CEO Marcelo Melchior emphasized that nutrition and health is among the company's four strategic growth priorities globally and in Brazil, encompassing some of its highest-value product categories.

Additional Expansion:

Beyond the new plant, Nestle plans to expand production capacity at its existing Aracatuba industrial complex in São Paulo state.

Market Implications:

This substantial investment signals Nestle's confidence in Brazil's growing infant formula market and positions the company to reduce import dependency while potentially establishing Brazil as a regional export hub. The multi-year commitment demonstrates long-term strategic focus on the nutrition and health sector in Latin America's largest economy, potentially strengthening Nestle's competitive position against rivals in the high-margin infant formula category.